ASMB Earnings Assembly Biosciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–31 of 31
| Q2 2026 | 2026-06-30 | -0.72 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.54 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.55 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -3.03 | 2025-11-10 | 10-Q |
| Q2 2026 | 2025-06-30 | -2.51 | 2026-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.17 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -6.69 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | -5.12 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.64 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.66 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -13.38 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -11.61 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -8.33 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -4.46 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -23.08 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.46 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.99 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.48 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -3.00 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -1.63 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.23 | 2022-08-09 | 10-Q |
| FY 2020 | 2020-12-31 | -1.11 | 2021-02-25 | 10-K |
| FY 2020 | 2020-09-30 | -0.09 | 2021-02-25 | 10-K |
| Q2 2021 | 2020-06-30 | -0.55 | 2021-08-05 | 10-Q |
| FY 2020 | 2020-03-31 | -0.76 | 2021-02-25 | 10-K |
| Q3 2019 | 2019-09-30 | -2.74 | 2019-11-07 | 10-Q |
| Q2 2020 | 2019-06-30 | -1.77 | 2020-08-05 | 10-Q |
| Q1 2020 | 2019-03-31 | -1.05 | 2020-05-08 | 10-Q |
| Q3 2019 | 2018-09-30 | -2.95 | 2019-11-07 | 10-Q |
| Q2 2019 | 2018-06-30 | -2.11 | 2019-08-05 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.80 | 2019-05-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.